| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0071 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.0094 | 1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.0081 | 1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |